Loading...
Loading...
Among the 4 tracked institutional investors we monitor, IBO (IMPACT BIOMEDICAL INC) is held with a combined value of $932.40K across 1,683,018 shares. The largest holder is VANGUARD GROUP INC with a position worth $411.52K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$932.40K
Total Shares Held
1,683,018
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $411.52K | 0.00% | New |
| 2 | STATE STREET CORP | $364.74K | 0.00% | +5053.0% |
| 3 | BlackRock, Inc. | $155.97K | 0.00% | - |
| 4 | FMR LLC | $174 | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of IBO with a position worth $411.52K, representing 0.00% of their portfolio. In total, 4 institutional investors hold IBO with a combined value of $932.40K.
In the most recent quarter, 2 funds opened a new position in IBO. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $932.40K worth of IBO stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $411.52K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IBO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IBO positions.